AI Liquid Biopsy Platform Shows Promise for Liver Cancer Detection
Positive liver cancer detection data demonstrates the promise of Delfi Diagnostics’ liquid biopsy platform in a new tumor type.
Read MorePosted by Chris Wolski | Nov 22, 2022 | Unknown Origin & Other Cancer Types |
Positive liver cancer detection data demonstrates the promise of Delfi Diagnostics’ liquid biopsy platform in a new tumor type.
Read MorePosted by Andy Lundin | Nov 18, 2022 | Unknown Origin & Other Cancer Types |
A new AI blood testing tech called DELFI successfully detected more than 80% of liver cancer cases in a new study.
Read MorePosted by Andy Lundin | Nov 8, 2022 | Tuberculosis |
Pioneering artificial intelligence (AI) which automatically diagnoses lung diseases could ease winter pressures on hospitals.
Read MorePosted by Andy Lundin | Nov 3, 2022 | Cancer, Sequencing Systems |
Precision for Medicine detailed its NGS initiative which aims to improve the accuracy and speed of identifying cancer mutations in tumors.
Read MorePosted by Chris Wolski | Oct 11, 2022 | Breast, Prostate |
More than two years after the COVID-19 pandemic began, cancer diagnoses continue to lag behind pre-pandemic levels.
Read More